Plasmacytoma Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Clinical Trials
• Forums

Daratumumab Combined With Bortezomib, Cyclophosphamide and Dexamethasone for the Treatment of Multiple Myeloma Patients Presenting With Extramedullary Disease
Conditions:   Multiple Myeloma;   Extramedullary Plasmacytoma Interventions:   Drug: Daratumumab;   Drug: Bortezomib;   Drug: Cyclophosphamide;   Drug: Dexamethasone Sponsors:   European Myeloma Network;   Janssen, LP Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 18, 2019 Category: Research Source Type: clinical trials

Daratumumab With DCEP for Multiple Myeloma With Plasmacytoma
Conditions:   Multiple Myeloma in Relapse;   Plasmacytoma;   Daratumumab Intervention:   Drug: Drug Combinations Sponsor:   Seoul National University Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 22, 2019 Category: Research Source Type: clinical trials